Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra- acetate (BOPTA) - Preliminary results of phase II clinical application

Radiology

Volumn 199, Issue 2, 1996, Pages 513-520

  Caudana, Roberto ^a   Morana, Giovanni ^a   Pirovano, Gian Paolo ^b   Nicoli, Nicola ^a   Portuese, Antonella ^a   Spinazzi, Alberto ^b   Di Rito, Rosa ^a   Pistolesi, Gian Franco ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Bracco SpA   (Italy)

Author keywords

Contrast media, 761.12143; Gadolinium, 761.12143; Liver neoplasms, MR, 761.33; Liver, MR, 761.12143; Magnetic resonance (MR), contrast agents, 761.12143

Indexed keywords

GADOBENIC ACID; GADOLINIUM PENTETATE; IOHEXOL; IOPAMIDOL; IOPAMINE 370; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGE QUALITY; INTRAVENOUS DRUG ADMINISTRATION; LIVER CANCER; LIVER METASTASIS; LIVER SCINTISCANNING; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION;

CONTRAST MEDIA; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0029913441     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.199.2.8668804     Document Type: Article

References (28)

1. Heiken JP, Weyman PJ, Lee JKT. Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging. Radiology 1989; 171:47-51.
2. Reinig JW, Dwyer AJ, Miller DL, et al. Liver metastasis detection: comparative sensitivity of MR imaging and CT scanning. Radiology 1987; 162:43-47.
3. Stark DD, Wittenberg J, Butch RJ, Ferrucci JT. Hepatic metastases: a randomized, controlled comparison of detection with MR and CT. Radiology 1987; 165:399-406.
4. Nelson RC, Chezmar JL, Sugarbaker PH, Bernardino ME. Hepatic tumors: comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation. Radiology 1989; 172:27-34.
5. Nazarian LN, Wechsler RJ, Grady CK, et al. CT done 4-6 hr after CT arterial portography: value in detecting hepatic tumors and differentiating from other hepatic perfusion defects. AJR 1994; 163:851-855.
6. Elizondo G, Fretz CJ, Stark DD, et al. Preclinical evaluation of Mn-DPDP: new paramagnetic hepatobiliary contrast agent for MR imaging. Radiology 1991; 178:73-78.
7. Lim KO, Stark DD, Leese PT, et al. Hepatobiliary MR imaging: first human experience with Mn-DPDP. Radiology 1991; 178: 79-82.
8. Hamm B, Vogl TJ, Branding G, et al. Focal liver lesions: MR imaging with Mn-DPDP-initial clinical results in 40 patients. Radiology 1992; 182:167-174.
9. Bernardino ME, Young SW, Lee JKT, Weinreb JC. Hepatic MR imaging with MnDPDP: safety, image quality, and sensitivity. Radiology 1992; 183:53-58.
10. Kreft BP, Tanimoto A, Baba Y, Zhao L, Finn JP, Stark DD. Enhanced tumor detection in the presence of fatty liver disease: cell-specific contrast agents. JMRI 1994; 4:337-342.
11. Rofsky NM, Weinreb JC, Bernardino ME, Young SW, Lee JK, Noz ME. Hepatocellular tumors: characterization with MnDPDP-enhanced MR imaging. Radiology 1993; 188:53-59.
12. Schumann-Gianpieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 1992; 183:59-64.
13. Muhler A, Clement O, Vexler V, et al. Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases. Radiology 199; 184:207-213.
14. Hamm B, Staks T, Muhler A, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary contrast agent: safety, pharmacokinetics and MR imaging. Radiology 1995; 195:785-792.
15. Vittadini G, Felder E, Tirone P, Lo Russo V. B-19036, a potential contrast agent for MR proton imaging. Invest Radiol 1988; 23(suppl 1):S246-S248.
16. Pavone P, Patrizio G, Buoni C, et al. Comparison of Gd-BOPTA with Gd-DTPA in MR imaging of rat liver. Radiology 1990; 176:61-64.
17. Lo Russo V, Pirovano G, Tirone P, Rosati G. Pharmacokinetics and tolerance of Gd-BOPTA/dimeg (abstr). JMRI 1992; 2(P): S18-S19, P233.
18. Vogl T, Pegios W, McMahon C, et al. Gadobenate dimeglumine: a new contrast agent for MR imaging - preliminary evaluation in healthy volunteers. AJR 1992; 158: 887-892.
19. Felder E, Uggeri F, Fumagalli L, Vittadini G, inventors. Bracco International B. V., Amersterdam, The Netherlands, assignee. Paramagnetic chelates useful for NMR imaging. US patent 4,916,246. 1990 Apr 10. Int Cl CO7F 13/00, CO7F 10.02.19236A/86. 1986 Jan 30.
20. Felder E, Fumagalli L, Uggeri F, Vittadini G, inventors. Bracco S. p. A., Milan, Italy, and Bracco International B. V., Amsterdam, The Netherlands, assignee. Paramagnetic chelates. European patent 0 230 893 B1. 1990 June 13. Int Cl CO7C 229/46, CO7C 233/10, CO7C 229/40, CO7D 401/12. IT 1923686. 1986 Jan 30.
21. Stark DD, Wittenberg J, Edelman RR, et al. Detection of hepatic metastases: analysis of pulse sequence performance in MR imaging. Radiology 1986; 159:365-370.
22. Schumann-Gianpieri G. Liver contrast media for magnetic resonance imaging: interrelations between pharmacokinetics and imaging. Invest Radiol 1993; 28:753-761.
23. Cavagna F, Tirone P, Felder E, de Haèn C. Hepatobiliary contrast agents for MRI. In: Ferrucci JT, Stark DD, eds. Liver imaging: current trends and new techniques. Boston, Mass: Andover Medical, 1990; 384-393.
24. Mahfouz AE, Hamm B, Wolf KJ. Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions. Radiology 1994; 190:49-52.
25. Ni Y, Marchal G, Zhang X, et al. The uptake of manganese dipyridoxaldiphosphate by chemically induced hepatocellular carcinoma in rats: a correlation between contrast-media-enhanced magnetic resonance imaging, tumor differentiation, and vascularization. Invest Radiol 1993; 28:520-528.
26. Ni Y, Marchal G, Yu J, Muhler A, Lukito G, Baert AL. Prolonged positive contrast enhancement with Gd-EOB-DTPA in experimental liver tumor: potential value in tissue characterization. JMRI 1994; 4:355-363.
27. Ebara M, Watanabe S, Kita K, et al. MR imaging of small hepatocellular carcinoma: effect of intratumoral copper content on signal intensity. Radiology 1991; 180:617-621.
28. Hamed MM, Hamm B, Ibrahim ME, et al. Dynamic MR imaging of the abdomen with gadopentetate dimeglumine: normal enhancement patterns of the liver, spleen, stomach and pancreas. AJR 1992; 158:303-307.